Incentives for Global Public Health (eBook, PDF)

Patent Law and Access to Essential Medicines
Redaktion: Pogge, Thomas

• Format: PDF

Produktbeschreibung

This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of 'creative capitalism'.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Cambridge University Press
• Erscheinungstermin: 24. Juni 2010
• Englisch
• ISBN-13: 9780511740961
• Artikelnr.: 38197104

Inhaltsangabe

Introduction: access to essential medicines: public health and
international law Thomas Pogge, Matthew Rimmer and Kim Rubenstein; Part I.
International Trade: 1. TRIPS and essential medicines: must one size fit
all? Making the WTO responsive to the global health crisis Rochelle Cooper
Dreyfuss; 2. The TRIPS waiver as a recognition of public health concerns in
the WTO Andrew Mitchell and Tania Voon; 3. Public law challenges to the
regulation of pharmaceutical patents in the US Bilateral Free Trade
Agreements Hitoshi Nasu; 4. Global health and development: patents and
public interest Elizabeth Siew Kuan Ng; Part II. Innovation: 5. The Health
Impact Fund: boosting innovation without obstructing free access Thomas
Pogge; 6. The Health Impact Fund: a critique Kathleen Liddell; 7. A prize
system as a partial solution to the health crisis in the developing world
William W. Fisher and Talha Syed; 8. Innovation and insufficient evidence:
the case for a WTO-WHO agreement on health technology safety and
cost-effectiveness evaluation Thomas Faunce; Part III. Intellectual
Property: 9. Opening the dam: patent pools, innovation, and access to
essential medicines Dianne Nicol and Jane Nielsen; 10. Open source drug
discovery: a revolutionary paradigm or a utopian model? Krishna Ravi
Srinivas; 11. Accessing and benefit sharing avian influenza viruses through
the World Health Organization: a CBD and TRIPS compromise thanks to
Indonesia's sovereignty claim? Charles Lawson and Barbara Hocking; 12. The
Lazarus effect: the (RED) campaign and creative capitalism Matthew Rimmer;
Part IV. Health-Care: 13. Beyond TRIPS: the role of non-state actors and
access to essential medicines Noah Benjamin Novogrodsky; 14. Securing
health through rights Katharine Young; 15. The role of national laws in
reconciling constitutional right to health with TRIPS obligations: an
examination of the Glivec patent case in India Rajshree Chandra; 16.
Tipping point: Thai compulsory licenses redefine essential medicines debate
Jonathan Burton-MacLeod.